Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00003038 · ClinicalTrials.gov registry record · Phase 1

Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors

A Phase 1 study of Breast Cancer and Prostate Cancer, sponsored by Mayo Clinic.

Completed
Registry status
Phase 1
Development phase
1
Study location

NCT00003038 is a Phase 1 study of Breast Cancer and Prostate Cancer that has completed, run by Mayo Clinic. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00003038, a Phase 1 study of Breast Cancer and Prostate Cancer, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
Phase 1
Development phase
1
Study location

Study Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy with suramin plus doxorubicin in treating patients with advanced solid tumors.

Conditions Studied

Breast Cancer Prostate Cancer Colorectal Cancer Unspecified Adult Solid Tumor, Protocol Specific Adrenocortical Carcinoma

Interventions

  • DRUG doxorubicin hydrochloride
  • DRUG suramin

Study Locations (1)

Minnesota

  • Mayo Clinic Cancer Center - Rochester

Trial Details

FieldValue
Start Date 1997-10
Est. Completion 2003-01
Phase Phase 1

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00003038

The ClinicalTrials.gov registry entry for NCT00003038 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which doxorubicin hydrochloride is the first listed.

NCT00003038 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT00003038 about?

NCT00003038 is a clinical study titled "Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy with suramin plus doxorubicin in treating pat...

What is the current status of trial NCT00003038?

This trial is currently completed. It is a Phase 1 study. The study started on 1997-10. Estimated completion is 2003-01.

What conditions does trial NCT00003038 study?

This clinical trial studies the following conditions: Breast Cancer, Prostate Cancer, Colorectal Cancer, Unspecified Adult Solid Tumor, Protocol Specific, Adrenocortical Carcinoma.

What interventions are being tested in trial NCT00003038?

The interventions under investigation include: doxorubicin hydrochloride (DRUG), suramin (DRUG).

Who is sponsoring clinical trial NCT00003038?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00003038 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Cancer

All registered trials for this condition

Prostate Cancer

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.